首页> 外文期刊>Терапевтичесκий архив >Recovery of peripheral blood lymphocytes in patients with hematological diseases after allogenic non-relative transplantation of hemopoietic stem cells
【24h】

Recovery of peripheral blood lymphocytes in patients with hematological diseases after allogenic non-relative transplantation of hemopoietic stem cells

机译:同种异体造血干细胞移植后血液系统疾病患者外周血淋巴细胞的恢复

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIM: To define impact of lymphopoiesis state on the results of transplantation of hemopoietic stem cells (THSC) by assessment of kinetics of lymphocyte count recovery in early posttransplantation period; to study correlation between THSC results and changes in composition of lymphocyte subpopulation. MATERIAL AND METHODS: Recipients of 122 non-relative THSC entered the trial. The recipients were adults with various hematological malignancies. RESULTS: Allogenic non-relative THSC leads to deep and long-lasting lymphopenia, low count of all lymphocyte subpopulations and, as a result, to marked impairment of antiinfectious and antitumor immune response. Kinetics of lymphopoiesis recovery depended on some clinical factors. Of most importance were duration of the disease before THSC, HLA donor and recipient compatibility, the source of stem cells, lymphocyte count in the transplant, administration of immunosuppressive drugs. Conduction of non-myeloablative regimens of conditioning did not reduce severity and duration of lymphopoiesis suppression. The time of lymphoid subpopulations count recovery had a significant influence on THSC results. Long-term lymphopenia increased the risk of severe infectious complications and recurrence. Low (under 500 lymphocytes in 1 mcl) lymphocyte level in peripheral blood one month after the transplantation was a death risk factor for patients after THSC. CONCLUSION: Dynamics of the recovery of lymphocyte subpopulations can be used for formulating policy of adaptive immunotherapy in patients after THSC.
机译:目的:通过评估移植后早期淋巴细胞计数恢复的动力学来确定淋巴细胞状态对造血干细胞(THSC)移植结果的影响;研究THSC结果与淋巴细胞亚群组成变化之间的相关性。材料与方法:122名非亲属THSC​​的接受者进入试验。接受者是患有各种血液恶性肿瘤的成年人。结果:同种异体非相对性THSC导致深层和持久性淋巴细胞减少,所有淋巴细胞亚群的数量减少,结果导致抗感染和抗肿瘤免疫反应的明显损伤。恢复淋巴细胞生成的动力学取决于一些临床因素。最重要的是THSC之前的病程,HLA供体和受体的相容性,干细胞的来源,移植中的淋巴细胞计数,免疫抑制药物的使用。进行非清髓性调理方案并不能降低抑制淋巴细胞生成的严重性和持续时间。淋巴细胞亚群计数恢复的时间对THSC结果有重要影响。长期淋巴细胞减少症增加了严重感染并发症和复发的风险。移植后一个月,外周血淋巴细胞水平低(低于1 mcl的500淋巴细胞以下)是THSC患者死亡的危险因素。结论:THSC后淋巴细胞亚群的恢复动态可用于制定适应性免疫治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号